Smoking influences response to inhaled corticosteroids in patients with asthma: A meta-analysis

Current Medical Research and Opinion

Volumn 28, Issue 11, 2012, Pages 1791-1798

  Zheng, Xueyan ^a   Guan, Weijie ^b   Zheng, Jinping ^b   Ye, Ping ^a   Liu, Shan ^a   Zhou, Junhua ^a   Xiong, Yiquan ^a   Zhang, Qionghua ^a   Chen, Qing ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Asthma; Inhaled corticosteroid; Meta analysis; Smoking

Indexed keywords

BECLOMETASONE; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; FORMOTEROL; MONTELUKAST; SALMETEROL;

ARTICLE; ASTHMA; DRUG EFFICACY; DRUG RESPONSE; HUMAN; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; SMOKING;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ASTHMA; HUMANS; RESPIRATORY FUNCTION TESTS; SMOKING;

EID: 84868676159     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2012.722991     Document Type: Article

References (31)

1. Sobande, PO, Kercsmar CM. Inhaled corticosteroids in asthma management. Respir Care 2008;53:625-33
2. Busse WW, Lemanske RF. Asthma. N Engl J Med 2001;344:350-62
3. Apostol GG, Jacobs DR, Tsai AW, et al. Early life factors contribute to the decrease in lung function between ages 18 and 40: the Coronary Artery Risk Development in Young Adults study. Am J Respir Crit Care Med 2002;166:166-72
4. Lange P, Ulrik CS, Vestbo J. Mortality in adults with self-reported asthma. Copenhagen City Heart Study Group. Lancet 1996;347:1285-9
5. Bellia V, Pedone C, Catalano F, et al. Asthma in the elderly: mortality rate and associated risk factors for mortality. Chest 2007;132:1175-82
6. Bethesda MD: National Institutes of Health, National Asthma Education and Prevention Program; 2007 NIH Publication No. 08-4051. Available at http://www.nhlbi.nih.gov/guidelines/asthma/asth-gdln.pdf. [last Accessed on May 12, 2012]
7. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2007. http://www.ginasthma.org. [last Accessed on May 12, 2012]
8. Siroux V, Pin I, Oryszczyn MP, et al. Relationships of active smoking to asthma and asthma severity in the EGEA study. Eur Respir J 2000;15:470-7
9. Tomlinson JEM, McMahon AD, Chaudhuri R, et al. Efficacy of low and high dose inhaled corticosteroid in smokers versus nonsmokers with mild asthma. Thorax 2005;60:282-7
10. Pedersen B, Dahl R, Karlstrom R, et al. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking. Am J Respir Crit Care Med 1996;153:1519-29
11. Chalmers GW, Macleod KJ, Little SA, et al. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002;57:226-30
12. Lazarus SC, Chinchilli VM, Rollings NJ, et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007;175:783-90
13. O'Byrne PM, Lamm CJ, Busse WW, et al. The effects of inhaled budesonide on lung function in smokers and nonsmokers with mild persistent asthma. Chest 2009;136:1514-20
14. Schayck OCP, Haughney J, Aubier M, et al. Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study. Respir Med 2012;106:189-96
15. Boulet LP, Deschesnes F, Chaboillez S, et al. Protocol: Influence of budeso-nide and budesonide/formoterol on asthma control in smoking asthmatic adults. Open Respir Med J 2010;4:51-7
16. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12
17. Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60
18. Hardy RJ, Thompson SG. Detecting and describing heterogeneity in meta analysis. Statist Med 1998;17:841-86
19. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88
20. Egger M, Smith DG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34
21. Harmsen L, Gottlieb V, Morkowsky M, et al. Asthma patients who smoke have signs of chronic airflow limitation before age 45. J Asthma 2010;47:362-6
22. Tsoumakidou M, Elston W, Zhu J, et al. Cigarette smoking alters bronchial mucosal immunity in asthma. Am J Respir Crit Care Med 2007;175:919-25
23. Clearie KL, McKinlay L, Williamson PA, et al. Fluticasone/salmeterol combination confers benefits in people with asthma who smoke. Chest 2012;141:330-8
24. Thomson NC, Chaudhuri R. Asthma in smokers: challenges and opportunities. Curr Opin Pulm Med 2009;15:39-45
25. Livingston E, Darroch C, Chaudhuri R, et al. Glucocorticoid receptor alpha to beta ratio in blood mononuclear cells is reduced in cigarette smokers. J Allergy Clin Immunol 2004;114:1475-8
26. Lewis-Tuffin LJ, Cidlowski JA. The physiology of human glucocorticoid receptor β (hGR/i) and glucocorticoid resistance. Ann N Y Acad Sci 2006;1069:1-9
27. Ito K, Lim S, Caramori G, et al. Cigarette smoking reduces histone deacety-lase2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 2001;15:1110-12
28. Ulrik CS, Lange P. Cigarette smoking and asthma. Monaldi Arch Chest Dis 2001;56:349-53
29. Siroux V, Pin I, Oryszczyn MP, et al. Relationships of active smoking to asthma and asthma severity in the EGEA study. Eur Respir J 2000;15:470-7
30. Silvermann RA, Boudreaux ED, Woodruff PG, et al. Cigarette smoking among asthmatic adults presenting to 64 emergency departments. Chest 2003;123:1472-9
31. Dijkstra A, Vonk JM, Jongepier H, et al. Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex. Thorax 2006;61:105-10